JanuaryCTWannLSCalkinsH, et al.2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society [published correction appears in J Am Coll Cardiol. 2019;74:599]. J Am Coll Cardiol. 2019;74:104–32.
2.
PareekMBhattDLTen BergJMKristensenSDGroveEL. Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention. Expert Opin Pharmacother. 2017;18:875–83.
3.
AxelrodMGilutzHPlakhtYGreenbergDNovackL. Early Atrial Fibrillation During Acute Myocardial Infarction May Not Be an Indication for Long-Term Anticoagulation. Angiology. 2020;71:559–66.
4.
LudhwaniDWietersJS. Paroxysmal Atrial Fibrillation. In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2020.
5.
FusterVRydénLEAsingerRW, et al.ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001;104:2118–50.
6.
RathoreSSBergerAKWeinfurtKP, et al.Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969–74.
7.
PattersonEPoSSScherlagBJLazzaraR. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005;2:624–31.
8.
LegalloisDGomesSPellissierAMilliezP. Medical emotional stress-induced atrial fibrillation: my own personal experience. Int J Cardiol. 2013;167:e182–3.
9.
MovsesianMA. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate. J Am Coll Cardiol. 1999;34:318–324.
10.
YuanWNieSWangHXuQJiaN. Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease. BMC Pulm Med. 2019;19:88.
11.
LiaoKMChenCY. Incidence and risk factors of atrial fibrillation in Asian COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2523–30.
12.
SawinCTGellerAWolfPBelangerA, et al.Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.
13.
ChenYCChenSAChenYJChangMSChanPLinCI. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol. 2002;39:366–72.
14.
ReddyVTahaWKundumadamSKhanM. Atrial fibrillation and hyperthyroidism: A literature review. Indian Heart J. 2017;69:545–55.
